Piper Sandler analyst Edward Tenthoff raised the price target on Dyne Therapeutics (NASDAQ: DYN) to $53.00 (from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE